HuGE Literature Finder
Cancer
Records
1
-
30
| [Initial Treatment of Aumolertinib in Combination with Bevacizumab for Advanced NSCLC with Primary EGFR T790M Mutation: A Report of Three Cases and Literature Review]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2023 3 26 (2): 158-164. Yang Xue, Meng Fanlu, Zhong Dianshe |
| A rare FGF5 candidate variant (rs112475347) for predisposition to non-squamous, non-small-cell lung cancer. International journal of cancer 2023 3 . Cannon-Albright Lisa A, Teerlink Craig C, Stevens Jeff, Facelli Julio C, Carr Shamus R, Allen-Brady Kristina, Puri Sonam, Bailey-Wilson Joan E, Musolf Anthony M, , Akerley Walla |
| Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer. Cancers 2023 3 15 (5): . Boyero Laura, Noguera-Uclés José Francisco, Castillo-Peña Alejandro, Salinas Ana, Sánchez-Gastaldo Amparo, Alonso Miriam, Benedetti Johana Cristina, Bernabé-Caro Reyes, Paz-Ares Luis, Molina-Pinelo Son |
| ALDH2 as a potential stem cell-related biomarker in lung adenocarcinoma: Comprehensive multi-omics analysis. Computational and structural biotechnology journal 2023 3 21 1921-1929. Tran Thi-Oanh, Vo Thanh Hoa, Lam Luu Ho Thanh, Le Nguyen Quoc Kha |
| Application of the Novel Grading System of Invasive Pulmonary Adenocarcinoma in a Real Diagnostic Scenario: A Brief Report of 9353 Cases. JTO clinical and research reports 2023 3 4 (3): 100465. She Yunlang, Zhong Yifan, Hou Likun, Zhao Shengnan, Zhang Liping, Xie Dong, Zhu Yuming, Wu Chunyan, Chen Cha |
| Clinical efficacy and safety of individualized pembrolizumab administration based on pharmacokinetic in advanced non-small cell lung cancer: A prospective exploratory clinical trial. Lung cancer (Amsterdam, Netherlands) 2023 3 178 183-190. Wang Na, Zheng Lie, Li Meichen, Hou Xue, Zhang Baishen, Chen Jing, Li Su, Chen Lik |
| Clinicopathological characteristics and molecular analysis of lung cancer associated with ciliated muconodular papillary tumor/bronchiolar adenoma. Pathology international 2023 3 . Higashiyama Masahiro, Motoi Noriko, Yotsukura Masaya, Yoshida Yukihiro, Nakagawa Kazuo, Yagishita Shigehiro, Shirasawa Masayuki, Yoshida Tatsuya, Shiraishi Kouya, Kohno Takashi, Ohe Yuichiro, Watanabe Shun-Ic |
| Discontinuation of Immune Checkpoint Inhibitor due to irAEs in NSCLC Patients With EGFR Mutation. Cancer diagnosis & prognosis 2023 3 3 (2): 244-250. Okauchi Shinichiro, Miyazaki Kunihiko, Shiozawa Toshihiro, Yamada Hideyasu, Satoh Hiroaki, Hizawa Nobuyu |
| Driver mutation characteristics of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2023 3 178 229-236. Daher Sameh, Zer Alona, Tschernichovsky Roi, Yacobi Rinat, Barshack Iris, Tsabari Shani, Rottenberg Yakir, Zick Aviad, Gottfried Teodor, Lobachov Anastasiya, Marom Edith M, Urban Damien, Saad Akram, Gantz-Sorotsky Hadas, Onn Amir, Bar Ja |
| Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring BRAF mutations. Translational lung cancer research 2023 3 12 (2): 219-229. Wang Haowei, Cheng Lei, Zhao Chao, Zhou Fei, Jiang Tao, Guo Haoyue, Shi Jinpeng, Chen Peixin, Tang Zhuoran, Mao Shiqi, Jia Keyi, Ye Lingyun, Cai Chenlei, Li Xuefei, Chen Xiaoxia, Zhou Caic |
| Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis. Open medicine (Warsaw, Poland) 2023 3 18 (1): 20230653. Gu Xiaodong, Si Jinfei, Guan Yelan, Xu Yibing, Shao Lan, Zhang Yiping, Xu Chunwei, Pan Weiwei, Lu Yuanzhi, Song Zhengbo, Wang Wenxi |
| Efficacy of osimertinib in patients with lung cancer positive for uncommon EGFR exon 19 deletion mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 3 . Grant Michael J, Aredo Jacqueline V, Starrett Jacqueline H, Stockhammer Paul, van Alderwerelt van Rosenburgh Iris K, Wurtz Anna, Piper-Valillo Andrew J, Piotrowska Zofia, Falcon Christina, Yu Helena A, Aggarwal Charu, Scholes Dylan, Patil Tejas, Nguyen Christina, Phadke Manali, Li Fang-Yong, Neal Joel, Lemmon Mark A, Walther Zenta, Politi Katerina, Goldberg Sarah |
| Epigenetic and genetic inactivation of tumor suppressor miR-135a in non-small-cell lung cancer. Thoracic cancer 2023 3 . Choi Jin Eun, Jeon Hyo Sung, Wee Hyun Jung, Lee Ji Yun, Lee Won Kee, Lee Shin Yup, Yoo Seung Soo, Choi Sun Ha, Kim Dong Sun, Park Jae Yo |
| Exploratory analysis of immunochemotherapy compared to chemotherapy after EGFR-TKI in non-small cell lung cancer patients with EGFR mutation: A multicenter retrospective study. Thoracic cancer 2023 3 . Hata Tae, Sakaguchi Chikara, Hirano Keita, Kobe Hiroshi, Ishida Masaki, Nakano Takayuki, Tachibana Yusuke, Tamiya Nobuyo, Shiotsu Shinsuke, Takeda Takayuki, Yamada Tadaaki, Yokoyama Toshihide, Tsuchiya Michiko, Nagasaka Yuk |
| First case report of ensartinib in a patient with metastatic ALK rearranged lung cancer with ALK I1171N mutation: a case report. World journal of surgical oncology 2023 3 21 (1): 74. Yang Shuang, Feng Weineng, Deng Yanming, Liang Jianmi |
| Genetic polymorphisms of MRPS30-DT and NINJ2 may influence lung cancer risk. Open medicine (Warsaw, Poland) 2023 3 18 (1): 20230655. Yan Shouchun, Wu Shouzhen, Wu Jia, Zhang Qinlu, He Yongjun, Jiang Chao, Jin Tian |
| Identification of FUT7 hypomethylation as the blood biomarker in prediction of early-stage lung cancer. Journal of genetics and genomics = Yi chuan xue bao 2023 3 . Qiao Rong, Di Feifei, Wang Jun, Wei Yujie, Xu Tian, Dai Liping, Gu Wanjian, Han Baohui, Yang Rong |
| Identifying polymorphic cis-regulatory variants as risk markers for lung carcinogenesis and chemotherapy responses in tobacco smokers from eastern India. Scientific reports 2023 3 13 (1): 4019. Sengupta Debmalya, Mukhopadhyay Pramiti, Banerjee Souradeep, Ganguly Kausik, Mascharak Prateek, Mukherjee Noyonika, Mitra Sangeeta, Bhattacharjee Samsiddhi, Mitra Ritabrata, Sarkar Abhijit, Chaudhuri Tamohan, Bhattacharjee Gautam, Nath Somsubhra, Roychoudhury Susanta, Sengupta Main |
| Immunogenetic variations predict immune-related adverse events for PD-1/PD-L1 inhibitors. European journal of cancer (Oxford, England : 1990) 2023 3 184 124-136. Xin Zhaodan, You Liting, Na Feifei, Li Jin, Chen Min, Song Jiajia, Bai Ling, Chen Jie, Zhou Juan, Ying Bin |
| Integrative genomic profiling reveals characteristics of lymph node metastasis in small cell lung cancer. Translational lung cancer research 2023 3 12 (2): 295-311. Kong Kangle, Hu Shan, Yue Jiaqi, Yang Ziheng, Jabbour Salma K, Deng Yu, Zhao Bo, Li F |
| Intracranial efficacy and safety of furmonertinib 160?mg with or without anti-angiogenic agent in advanced NSCLC patients with BM/LM as salvage therapy. BMC cancer 2023 3 23 (1): 206. Xu Ziyi, Hao Xuezhi, Wang Qi, Yang Ke, Li Junling, Xing Puyu |
| Laboratory blood test profiling reveals distinct biochemical and hemocyte features of KRAS mutated non-small cell lung cancer. Journal of thoracic disease 2023 3 15 (2): 365-375. Ou Limin, Cai Xiuyu, Zeng Wenchuang, Huang Liyan, Deng Qiuhua, Tang Hailing, Chen Zhuxing, Zhou Huan, Lin Yongping, Liu Liping, Liang Wenh |
| Metabolomic, DNA methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells. Cancer prevention research (Philadelphia, Pa.) 2023 3 . Chou Pochung Jordan, Sarwar Md Shahid, Wang Lujing, Wu Renyi, Li Shanyi, Hudlikar Rasika R, Wang Yujue, Su Xiaoyang, Kong Ah- |
| Myo1e overexpression in lung adenocarcinoma is associated with increased risk of mortality. Scientific reports 2023 3 13 (1): 4107. Jusue-Torres Ignacio, Tiv Richies, Ricarte-Filho Julio C, Mallisetty Apurva, Contreras-Vargas Leglys, Godoy-Calderon Maria Jose, Khaddour Karam, Kennedy Kathleen, Valyi-Nagy Klara, David Odile, Menchaca Martha, Kottorou Anastasia, Koutras Angelos, Dimitrakopoulos Foteinos, Abdelhady Khaled M, Massad Malek, Rubinstein Israel, Feldman Lawrence, Stewart John, Shimamura Takeshi, Danilova Ludmila, Hulbert Alic |
| Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: a real-world study. BMC cancer 2023 3 23 (1): 198. Sun Haiyan, Ren Peng, Chen Yongzi, Lan Lan, Yan Zhuchen, Yang Yinli, Wang Bin, Wang Cong, Li Yanwei, Li Ling, Zhang Yu, Li Yanyang, Wang Zuolin, Pan Zhanyu, Jiang Zhanshe |
| Pharmacokinetic/Pharmacodynamic Analysis of Savolitinib Plus Osimertinib in an EGFR-Mutation Positive, MET-Amplified Non-Small Cell Lung Cancer Model. Molecular cancer therapeutics 2023 3 . Jones Rhys D O, Petersson Klas, Tabatabai Areya, Bao Larry, Tomkinson Helen, Schuller Alwin |
| Prognostic value of cell-free DNA in cerebrospinal fluid from lung cancer patients with brain metastases during radiotherapy. Radiation oncology (London, England) 2023 3 18 (1): 50. Qiao Simiao, Hao Yuying, Cai Linbo, Duan Xiaotong, Wang Lijuan, Zhou Aidong, Zhu Xiaox |
| Real-world retrospective study of KRAS mutations in advanced nonsmall cell lung cancer in the era of immunotherapy. Cancer 2023 3 . Bironzo Paolo, Cani Massimiliano, Jacobs Francesca, Napoli Valerio M, Listì Angela, Passiglia Francesco, Righi Luisella, Di Maio Massimo, Novello Silvia, Scagliotti Giorgio |
| Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo). Lung cancer (Amsterdam, Netherlands) 2023 3 178 191-197. Vergnenegre Alain, Monnet Isabelle, Ricordel Charles, Bizieux Acya, Curcio Hubert, Bernardi Marie, Corre Romain, Guisier Florian, Hominal Stéphane, Le Garff Gwenaelle, Bylicki Olivier, Locher Chrystèle, Geier Margaux, Chouaïd Christos, Robinet Gilles, |
| Uses of Vascular Endothelial Growth Factor C as a Lung Adenocarcinoma Prognostic Biomarker. World journal of oncology 2023 3 14 (1): 51-59. Chen Shi, Pan Ting Yu, Wu Xiao, Li Tian, Wei Yu, He Hai Lang, Zhou Xian Mei, Wang Qian, Zhu Ji Pi |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: